Overview of ALK and ROS1 Rearranged Lung Cancer
Chang Min Choi
Tuberc Respir Dis. 2013;75(6):236-237.   Published online 2013 Dec 24     DOI: https://doi.org/10.4046/trd.2013.75.6.236
Citations to this article as recorded by Crossref logo
Molecular Simulation Studies on the Binding Selectivity of Type-I Inhibitors in the Complexes with ROS1 versus ALK
Yuanxin Tian, Yonghuan Yu, Yudong Shen, Hua Wan, Shan Chang, Tingting Zhang, Shanhe Wan, Jiajie Zhang
Journal of Chemical Information and Modeling.2017; 57(4): 977.     CrossRef
Advanced Adenocarcinoma of the Lung: Comparison of CT Characteristics of Patients with Anaplastic Lymphoma Kinase Gene Rearrangement and Those with Epidermal Growth Factor Receptor Mutation
Chang-Min Choi, Mi Young Kim, Hye Jeon Hwang, Jung Bok Lee, Woo Sung Kim
Radiology.2015; 275(1): 272.     CrossRef
Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors
Makoto Nishio, Haruyasu Murakami, Atsushi Horiike, Toshiaki Takahashi, Fumihiko Hirai, Naoko Suenaga, Takeshi Tajima, Kota Tokushige, Masami Ishii, Anthony Boral, Matthew Robson, Takashi Seto
Journal of Thoracic Oncology.2015; 10(7): 1058.     CrossRef
Chromosomal rearrangements in cancer
Paul Hasty, Cristina Montagna
Molecular & Cellular Oncology.2014; 1(1): e29904.     CrossRef